PATHOLOGY RESEARCH AND PRACTICE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=999340, encodeId=f152999340cc, content=我的论文Required Reviews Completed，这个大概需要多久啊？接收的概率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de965352151, createdName=刘娟5835, createdTime=Wed Jul 14 11:23:48 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914157, encodeId=84a791415e29, content=2020.9.15投稿，2020.9.17 review 2021.1.6reject 中间发了两次邮件询问审稿情况，均恢复说只有一个审稿人意见返回，结果今天回复找不到审稿人，拒稿，心累…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19615409816, createdName=ms8000000599164467, createdTime=Wed Jan 06 18:42:43 CST 2021, time=2021-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587662, encodeId=8fa358e662c1, content=刚投了一篇，被拒了小米 2020-03-15 00:00:00 发表: 纯生信还要吗, beContent=小米 2020-03-15 00:00:00 发表: 纯生信还要吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Sat Mar 28 00:00:00 CST 2020, time=2020-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219190, encodeId=ba0e121919097, content=请问怎么能够找到这个杂志的格式要求啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7b58152381, createdName=ms9000000125016448, createdTime=Thu May 12 22:30:01 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584426, encodeId=3bb0584426b7, content=您好！病理个案好投吗？caomeng13001_34315622 2019-09-03 发表:: 研究方向：病理学;肿瘤病理;细胞生物学接收率：约50% 审稿时间：约2个月在这个杂志投过两篇论文，总体感觉是很nice的杂志。两次都是4月中旬投稿，with editor大概三五天，就开始under review。5月底收到审稿人的修改意见，意见很专业也很细致。第一次小修用了大约半个月，第二次大修将近三个月。两次都是修回后半个月内接收。推荐病理方向相关的论文试一试这个杂志！caomeng13001_34315622 2019-09-03 15:38:00 发表: 在这个杂志投过两篇论文，总体感觉是很nice的杂志。两次都是4月中旬投稿，with editor大概三五天，就开始under review。5月底收到审稿人的修改意见，意见很专业也很细致。第一次小修用了大约半个月，第二次大修将近三个月。两次都是修回后半个月内接收。推荐病理方向相关的论文试一试这个杂志！, beContent=caomeng13001_34315622 2019-09-03 发表:: 研究方向：病理学;肿瘤病理;细胞生物学接收率：约50% 审稿时间：约2个月在这个杂志投过两篇论文，总体感觉是很nice的杂志。两次都是4月中旬投稿，with editor大概三五天，就开始under review。5月底收到审稿人的修改意见，意见很专业也很细致。第一次小修用了大约半个月，第二次大修将近三个月。两次都是修回后半个月内接收。推荐病理方向相关的论文试一试这个杂志！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/08/bcaa9c02cdc86c850bed66bd80d62afc.jpg, createdBy=a6a15275344, createdName=幸福悠然1985, createdTime=Sat Feb 08 00:00:00 CST 2020, time=2020-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926204, encodeId=8ba592620475, content=这个杂志接受纯生信吗？刚被隔壁biomed res int拒了，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Sun Feb 21 19:58:55 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590496, encodeId=256a5904966b, content=隔一个月直接接收了肥皂冒泡 2020-04-27 00:00:00 发表: 小修后，已经20多天了，一直是with editor ……, beContent=肥皂冒泡 2020-04-27 00:00:00 发表: 小修后，已经20多天了，一直是with editor ……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/bd660048b8b8a90d25fec71869d21df4.jpg, createdBy=fb441602893, createdName=肥皂冒泡, createdTime=Sat May 09 00:00:00 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587770, encodeId=5f3958e77021, content=请问疫情审稿延迟了？我under review一个月没动静呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec4a2554356, createdName=1254b90bm49(暂无昵称), createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586651, encodeId=a89e5866515c, content=纯生信还要吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/tibII0b4lRfFhLvFjAa2ia6c3aZRprZkkvq9RQBKcYG8pOJSRjqhQLLGgA63ogn5sAj4Md9y5D9MWu0zDrpLQgtQ/132, createdBy=b89a5237824, createdName=小米7909, createdTime=Sun Mar 15 00:00:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800711, encodeId=9711800e110b, content=快一个月了只到reviewer invited阶段，有遇到过吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a83e5207147, createdName=1475071cm29(暂无昵称), createdTime=Wed Jul 01 05:55:12 CST 2020, time=2020-07-01, status=1, ipAttribution=)]

2021-07-14 刘娟5835

我的论文Required Reviews Completed，这个大概需要多久啊？接收的概率大吗？

64 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=999340, encodeId=f152999340cc, content=我的论文Required Reviews Completed，这个大概需要多久啊？接收的概率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de965352151, createdName=刘娟5835, createdTime=Wed Jul 14 11:23:48 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914157, encodeId=84a791415e29, content=2020.9.15投稿，2020.9.17 review 2021.1.6reject 中间发了两次邮件询问审稿情况，均恢复说只有一个审稿人意见返回，结果今天回复找不到审稿人，拒稿，心累…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19615409816, createdName=ms8000000599164467, createdTime=Wed Jan 06 18:42:43 CST 2021, time=2021-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587662, encodeId=8fa358e662c1, content=刚投了一篇，被拒了小米 2020-03-15 00:00:00 发表: 纯生信还要吗, beContent=小米 2020-03-15 00:00:00 发表: 纯生信还要吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Sat Mar 28 00:00:00 CST 2020, time=2020-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219190, encodeId=ba0e121919097, content=请问怎么能够找到这个杂志的格式要求啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7b58152381, createdName=ms9000000125016448, createdTime=Thu May 12 22:30:01 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584426, encodeId=3bb0584426b7, content=您好！病理个案好投吗？caomeng13001_34315622 2019-09-03 发表:: 研究方向：病理学;肿瘤病理;细胞生物学接收率：约50% 审稿时间：约2个月在这个杂志投过两篇论文，总体感觉是很nice的杂志。两次都是4月中旬投稿，with editor大概三五天，就开始under review。5月底收到审稿人的修改意见，意见很专业也很细致。第一次小修用了大约半个月，第二次大修将近三个月。两次都是修回后半个月内接收。推荐病理方向相关的论文试一试这个杂志！caomeng13001_34315622 2019-09-03 15:38:00 发表: 在这个杂志投过两篇论文，总体感觉是很nice的杂志。两次都是4月中旬投稿，with editor大概三五天，就开始under review。5月底收到审稿人的修改意见，意见很专业也很细致。第一次小修用了大约半个月，第二次大修将近三个月。两次都是修回后半个月内接收。推荐病理方向相关的论文试一试这个杂志！, beContent=caomeng13001_34315622 2019-09-03 发表:: 研究方向：病理学;肿瘤病理;细胞生物学接收率：约50% 审稿时间：约2个月在这个杂志投过两篇论文，总体感觉是很nice的杂志。两次都是4月中旬投稿，with editor大概三五天，就开始under review。5月底收到审稿人的修改意见，意见很专业也很细致。第一次小修用了大约半个月，第二次大修将近三个月。两次都是修回后半个月内接收。推荐病理方向相关的论文试一试这个杂志！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/08/bcaa9c02cdc86c850bed66bd80d62afc.jpg, createdBy=a6a15275344, createdName=幸福悠然1985, createdTime=Sat Feb 08 00:00:00 CST 2020, time=2020-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926204, encodeId=8ba592620475, content=这个杂志接受纯生信吗？刚被隔壁biomed res int拒了，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Sun Feb 21 19:58:55 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590496, encodeId=256a5904966b, content=隔一个月直接接收了肥皂冒泡 2020-04-27 00:00:00 发表: 小修后，已经20多天了，一直是with editor ……, beContent=肥皂冒泡 2020-04-27 00:00:00 发表: 小修后，已经20多天了，一直是with editor ……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/bd660048b8b8a90d25fec71869d21df4.jpg, createdBy=fb441602893, createdName=肥皂冒泡, createdTime=Sat May 09 00:00:00 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587770, encodeId=5f3958e77021, content=请问疫情审稿延迟了？我under review一个月没动静呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec4a2554356, createdName=1254b90bm49(暂无昵称), createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586651, encodeId=a89e5866515c, content=纯生信还要吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/tibII0b4lRfFhLvFjAa2ia6c3aZRprZkkvq9RQBKcYG8pOJSRjqhQLLGgA63ogn5sAj4Md9y5D9MWu0zDrpLQgtQ/132, createdBy=b89a5237824, createdName=小米7909, createdTime=Sun Mar 15 00:00:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800711, encodeId=9711800e110b, content=快一个月了只到reviewer invited阶段，有遇到过吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a83e5207147, createdName=1475071cm29(暂无昵称), createdTime=Wed Jul 01 05:55:12 CST 2020, time=2020-07-01, status=1, ipAttribution=)]

2021-01-06 ms8000000599164467

2020.9.15投稿，2020.9.17 review 2021.1.6reject 中间发了两次邮件询问审稿情况，均恢复说只有一个审稿人意见返回，结果今天回复找不到审稿人，拒稿，心累…

91 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=999340, encodeId=f152999340cc, content=我的论文Required Reviews Completed，这个大概需要多久啊？接收的概率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de965352151, createdName=刘娟5835, createdTime=Wed Jul 14 11:23:48 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914157, encodeId=84a791415e29, content=2020.9.15投稿，2020.9.17 review 2021.1.6reject 中间发了两次邮件询问审稿情况，均恢复说只有一个审稿人意见返回，结果今天回复找不到审稿人，拒稿，心累…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19615409816, createdName=ms8000000599164467, createdTime=Wed Jan 06 18:42:43 CST 2021, time=2021-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587662, encodeId=8fa358e662c1, content=刚投了一篇，被拒了小米 2020-03-15 00:00:00 发表: 纯生信还要吗, beContent=小米 2020-03-15 00:00:00 发表: 纯生信还要吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Sat Mar 28 00:00:00 CST 2020, time=2020-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219190, encodeId=ba0e121919097, content=请问怎么能够找到这个杂志的格式要求啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7b58152381, createdName=ms9000000125016448, createdTime=Thu May 12 22:30:01 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584426, encodeId=3bb0584426b7, content=您好！病理个案好投吗？caomeng13001_34315622 2019-09-03 发表:: 研究方向：病理学;肿瘤病理;细胞生物学接收率：约50% 审稿时间：约2个月在这个杂志投过两篇论文，总体感觉是很nice的杂志。两次都是4月中旬投稿，with editor大概三五天，就开始under review。5月底收到审稿人的修改意见，意见很专业也很细致。第一次小修用了大约半个月，第二次大修将近三个月。两次都是修回后半个月内接收。推荐病理方向相关的论文试一试这个杂志！caomeng13001_34315622 2019-09-03 15:38:00 发表: 在这个杂志投过两篇论文，总体感觉是很nice的杂志。两次都是4月中旬投稿，with editor大概三五天，就开始under review。5月底收到审稿人的修改意见，意见很专业也很细致。第一次小修用了大约半个月，第二次大修将近三个月。两次都是修回后半个月内接收。推荐病理方向相关的论文试一试这个杂志！, beContent=caomeng13001_34315622 2019-09-03 发表:: 研究方向：病理学;肿瘤病理;细胞生物学接收率：约50% 审稿时间：约2个月在这个杂志投过两篇论文，总体感觉是很nice的杂志。两次都是4月中旬投稿，with editor大概三五天，就开始under review。5月底收到审稿人的修改意见，意见很专业也很细致。第一次小修用了大约半个月，第二次大修将近三个月。两次都是修回后半个月内接收。推荐病理方向相关的论文试一试这个杂志！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/08/bcaa9c02cdc86c850bed66bd80d62afc.jpg, createdBy=a6a15275344, createdName=幸福悠然1985, createdTime=Sat Feb 08 00:00:00 CST 2020, time=2020-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926204, encodeId=8ba592620475, content=这个杂志接受纯生信吗？刚被隔壁biomed res int拒了，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Sun Feb 21 19:58:55 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590496, encodeId=256a5904966b, content=隔一个月直接接收了肥皂冒泡 2020-04-27 00:00:00 发表: 小修后，已经20多天了，一直是with editor ……, beContent=肥皂冒泡 2020-04-27 00:00:00 发表: 小修后，已经20多天了，一直是with editor ……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/bd660048b8b8a90d25fec71869d21df4.jpg, createdBy=fb441602893, createdName=肥皂冒泡, createdTime=Sat May 09 00:00:00 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587770, encodeId=5f3958e77021, content=请问疫情审稿延迟了？我under review一个月没动静呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec4a2554356, createdName=1254b90bm49(暂无昵称), createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586651, encodeId=a89e5866515c, content=纯生信还要吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/tibII0b4lRfFhLvFjAa2ia6c3aZRprZkkvq9RQBKcYG8pOJSRjqhQLLGgA63ogn5sAj4Md9y5D9MWu0zDrpLQgtQ/132, createdBy=b89a5237824, createdName=小米7909, createdTime=Sun Mar 15 00:00:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800711, encodeId=9711800e110b, content=快一个月了只到reviewer invited阶段，有遇到过吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a83e5207147, createdName=1475071cm29(暂无昵称), createdTime=Wed Jul 01 05:55:12 CST 2020, time=2020-07-01, status=1, ipAttribution=)]

2020-03-28 14697858m50(暂无昵称)

刚投了一篇，被拒了小米 2020-03-15 00:00:00 发表:
纯生信还要吗

小米 2020-03-15 00:00:00 发表: 纯生信还要吗

117 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=999340, encodeId=f152999340cc, content=我的论文Required Reviews Completed，这个大概需要多久啊？接收的概率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de965352151, createdName=刘娟5835, createdTime=Wed Jul 14 11:23:48 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914157, encodeId=84a791415e29, content=2020.9.15投稿，2020.9.17 review 2021.1.6reject 中间发了两次邮件询问审稿情况，均恢复说只有一个审稿人意见返回，结果今天回复找不到审稿人，拒稿，心累…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19615409816, createdName=ms8000000599164467, createdTime=Wed Jan 06 18:42:43 CST 2021, time=2021-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587662, encodeId=8fa358e662c1, content=刚投了一篇，被拒了小米 2020-03-15 00:00:00 发表: 纯生信还要吗, beContent=小米 2020-03-15 00:00:00 发表: 纯生信还要吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Sat Mar 28 00:00:00 CST 2020, time=2020-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219190, encodeId=ba0e121919097, content=请问怎么能够找到这个杂志的格式要求啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7b58152381, createdName=ms9000000125016448, createdTime=Thu May 12 22:30:01 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584426, encodeId=3bb0584426b7, content=您好！病理个案好投吗？caomeng13001_34315622 2019-09-03 发表:: 研究方向：病理学;肿瘤病理;细胞生物学接收率：约50% 审稿时间：约2个月在这个杂志投过两篇论文，总体感觉是很nice的杂志。两次都是4月中旬投稿，with editor大概三五天，就开始under review。5月底收到审稿人的修改意见，意见很专业也很细致。第一次小修用了大约半个月，第二次大修将近三个月。两次都是修回后半个月内接收。推荐病理方向相关的论文试一试这个杂志！caomeng13001_34315622 2019-09-03 15:38:00 发表: 在这个杂志投过两篇论文，总体感觉是很nice的杂志。两次都是4月中旬投稿，with editor大概三五天，就开始under review。5月底收到审稿人的修改意见，意见很专业也很细致。第一次小修用了大约半个月，第二次大修将近三个月。两次都是修回后半个月内接收。推荐病理方向相关的论文试一试这个杂志！, beContent=caomeng13001_34315622 2019-09-03 发表:: 研究方向：病理学;肿瘤病理;细胞生物学接收率：约50% 审稿时间：约2个月在这个杂志投过两篇论文，总体感觉是很nice的杂志。两次都是4月中旬投稿，with editor大概三五天，就开始under review。5月底收到审稿人的修改意见，意见很专业也很细致。第一次小修用了大约半个月，第二次大修将近三个月。两次都是修回后半个月内接收。推荐病理方向相关的论文试一试这个杂志！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/08/bcaa9c02cdc86c850bed66bd80d62afc.jpg, createdBy=a6a15275344, createdName=幸福悠然1985, createdTime=Sat Feb 08 00:00:00 CST 2020, time=2020-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926204, encodeId=8ba592620475, content=这个杂志接受纯生信吗？刚被隔壁biomed res int拒了，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Sun Feb 21 19:58:55 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590496, encodeId=256a5904966b, content=隔一个月直接接收了肥皂冒泡 2020-04-27 00:00:00 发表: 小修后，已经20多天了，一直是with editor ……, beContent=肥皂冒泡 2020-04-27 00:00:00 发表: 小修后，已经20多天了，一直是with editor ……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/bd660048b8b8a90d25fec71869d21df4.jpg, createdBy=fb441602893, createdName=肥皂冒泡, createdTime=Sat May 09 00:00:00 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587770, encodeId=5f3958e77021, content=请问疫情审稿延迟了？我under review一个月没动静呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec4a2554356, createdName=1254b90bm49(暂无昵称), createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586651, encodeId=a89e5866515c, content=纯生信还要吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/tibII0b4lRfFhLvFjAa2ia6c3aZRprZkkvq9RQBKcYG8pOJSRjqhQLLGgA63ogn5sAj4Md9y5D9MWu0zDrpLQgtQ/132, createdBy=b89a5237824, createdName=小米7909, createdTime=Sun Mar 15 00:00:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800711, encodeId=9711800e110b, content=快一个月了只到reviewer invited阶段，有遇到过吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a83e5207147, createdName=1475071cm29(暂无昵称), createdTime=Wed Jul 01 05:55:12 CST 2020, time=2020-07-01, status=1, ipAttribution=)]

2022-05-12 ms9000000125016448

请问怎么能够找到这个杂志的格式要求啊

36 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=999340, encodeId=f152999340cc, content=我的论文Required Reviews Completed，这个大概需要多久啊？接收的概率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de965352151, createdName=刘娟5835, createdTime=Wed Jul 14 11:23:48 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914157, encodeId=84a791415e29, content=2020.9.15投稿，2020.9.17 review 2021.1.6reject 中间发了两次邮件询问审稿情况，均恢复说只有一个审稿人意见返回，结果今天回复找不到审稿人，拒稿，心累…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19615409816, createdName=ms8000000599164467, createdTime=Wed Jan 06 18:42:43 CST 2021, time=2021-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587662, encodeId=8fa358e662c1, content=刚投了一篇，被拒了小米 2020-03-15 00:00:00 发表: 纯生信还要吗, beContent=小米 2020-03-15 00:00:00 发表: 纯生信还要吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Sat Mar 28 00:00:00 CST 2020, time=2020-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219190, encodeId=ba0e121919097, content=请问怎么能够找到这个杂志的格式要求啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7b58152381, createdName=ms9000000125016448, createdTime=Thu May 12 22:30:01 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584426, encodeId=3bb0584426b7, content=您好！病理个案好投吗？caomeng13001_34315622 2019-09-03 发表:: 研究方向：病理学;肿瘤病理;细胞生物学接收率：约50% 审稿时间：约2个月在这个杂志投过两篇论文，总体感觉是很nice的杂志。两次都是4月中旬投稿，with editor大概三五天，就开始under review。5月底收到审稿人的修改意见，意见很专业也很细致。第一次小修用了大约半个月，第二次大修将近三个月。两次都是修回后半个月内接收。推荐病理方向相关的论文试一试这个杂志！caomeng13001_34315622 2019-09-03 15:38:00 发表: 在这个杂志投过两篇论文，总体感觉是很nice的杂志。两次都是4月中旬投稿，with editor大概三五天，就开始under review。5月底收到审稿人的修改意见，意见很专业也很细致。第一次小修用了大约半个月，第二次大修将近三个月。两次都是修回后半个月内接收。推荐病理方向相关的论文试一试这个杂志！, beContent=caomeng13001_34315622 2019-09-03 发表:: 研究方向：病理学;肿瘤病理;细胞生物学接收率：约50% 审稿时间：约2个月在这个杂志投过两篇论文，总体感觉是很nice的杂志。两次都是4月中旬投稿，with editor大概三五天，就开始under review。5月底收到审稿人的修改意见，意见很专业也很细致。第一次小修用了大约半个月，第二次大修将近三个月。两次都是修回后半个月内接收。推荐病理方向相关的论文试一试这个杂志！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/08/bcaa9c02cdc86c850bed66bd80d62afc.jpg, createdBy=a6a15275344, createdName=幸福悠然1985, createdTime=Sat Feb 08 00:00:00 CST 2020, time=2020-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926204, encodeId=8ba592620475, content=这个杂志接受纯生信吗？刚被隔壁biomed res int拒了，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Sun Feb 21 19:58:55 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590496, encodeId=256a5904966b, content=隔一个月直接接收了肥皂冒泡 2020-04-27 00:00:00 发表: 小修后，已经20多天了，一直是with editor ……, beContent=肥皂冒泡 2020-04-27 00:00:00 发表: 小修后，已经20多天了，一直是with editor ……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/bd660048b8b8a90d25fec71869d21df4.jpg, createdBy=fb441602893, createdName=肥皂冒泡, createdTime=Sat May 09 00:00:00 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587770, encodeId=5f3958e77021, content=请问疫情审稿延迟了？我under review一个月没动静呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec4a2554356, createdName=1254b90bm49(暂无昵称), createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586651, encodeId=a89e5866515c, content=纯生信还要吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/tibII0b4lRfFhLvFjAa2ia6c3aZRprZkkvq9RQBKcYG8pOJSRjqhQLLGgA63ogn5sAj4Md9y5D9MWu0zDrpLQgtQ/132, createdBy=b89a5237824, createdName=小米7909, createdTime=Sun Mar 15 00:00:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800711, encodeId=9711800e110b, content=快一个月了只到reviewer invited阶段，有遇到过吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a83e5207147, createdName=1475071cm29(暂无昵称), createdTime=Wed Jul 01 05:55:12 CST 2020, time=2020-07-01, status=1, ipAttribution=)]

2020-02-08 幸福悠然1985

您好！病理个案好投吗？caomeng13001_34315622 2019-09-03 发表::
研究方向：病理学;肿瘤病理;细胞生物学接收率：约50% 审稿时间：约2个月在这个杂志投过两篇论文，总体感觉是很nice的杂志。两次都是4月中旬投稿，with editor大概三五天，就开始under review。5月底收到审稿人的修改意见，意见很专业也很细致。第一次小修用了大约半个月，第二次大修将近三个月。两次都是修回后半个月内接收。推荐病理方向相关的论文试一试这个杂志！caomeng13001_34315622 2019-09-03 15:38:00 发表:
在这个杂志投过两篇论文，总体感觉是很nice的杂志。两次都是4月中旬投稿，with editor大概三五天，就开始under review。5月底收到审稿人的修改意见，意见很专业也很细致。第一次小修用了大约半个月，第二次大修将近三个月。两次都是修回后半个月内接收。推荐病理方向相关的论文试一试这个杂志！

caomeng13001_34315622 2019-09-03 发表:: 研究方向：病理学;肿瘤病理;细胞生物学接收率：约50% 审稿时间：约2个月在这个杂志投过两篇论文，总体感觉是很nice的杂志。两次都是4月中旬投稿，with editor大概三五天，就开始under review。5月底收到审稿人的修改意见，意见很专业也很细致。第一次小修用了大约半个月，第二次大修将近三个月。两次都是修回后半个月内接收。推荐病理方向相关的论文试一试这个杂志！

95 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=999340, encodeId=f152999340cc, content=我的论文Required Reviews Completed，这个大概需要多久啊？接收的概率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de965352151, createdName=刘娟5835, createdTime=Wed Jul 14 11:23:48 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914157, encodeId=84a791415e29, content=2020.9.15投稿，2020.9.17 review 2021.1.6reject 中间发了两次邮件询问审稿情况，均恢复说只有一个审稿人意见返回，结果今天回复找不到审稿人，拒稿，心累…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19615409816, createdName=ms8000000599164467, createdTime=Wed Jan 06 18:42:43 CST 2021, time=2021-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587662, encodeId=8fa358e662c1, content=刚投了一篇，被拒了小米 2020-03-15 00:00:00 发表: 纯生信还要吗, beContent=小米 2020-03-15 00:00:00 发表: 纯生信还要吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Sat Mar 28 00:00:00 CST 2020, time=2020-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219190, encodeId=ba0e121919097, content=请问怎么能够找到这个杂志的格式要求啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7b58152381, createdName=ms9000000125016448, createdTime=Thu May 12 22:30:01 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584426, encodeId=3bb0584426b7, content=您好！病理个案好投吗？caomeng13001_34315622 2019-09-03 发表:: 研究方向：病理学;肿瘤病理;细胞生物学接收率：约50% 审稿时间：约2个月在这个杂志投过两篇论文，总体感觉是很nice的杂志。两次都是4月中旬投稿，with editor大概三五天，就开始under review。5月底收到审稿人的修改意见，意见很专业也很细致。第一次小修用了大约半个月，第二次大修将近三个月。两次都是修回后半个月内接收。推荐病理方向相关的论文试一试这个杂志！caomeng13001_34315622 2019-09-03 15:38:00 发表: 在这个杂志投过两篇论文，总体感觉是很nice的杂志。两次都是4月中旬投稿，with editor大概三五天，就开始under review。5月底收到审稿人的修改意见，意见很专业也很细致。第一次小修用了大约半个月，第二次大修将近三个月。两次都是修回后半个月内接收。推荐病理方向相关的论文试一试这个杂志！, beContent=caomeng13001_34315622 2019-09-03 发表:: 研究方向：病理学;肿瘤病理;细胞生物学接收率：约50% 审稿时间：约2个月在这个杂志投过两篇论文，总体感觉是很nice的杂志。两次都是4月中旬投稿，with editor大概三五天，就开始under review。5月底收到审稿人的修改意见，意见很专业也很细致。第一次小修用了大约半个月，第二次大修将近三个月。两次都是修回后半个月内接收。推荐病理方向相关的论文试一试这个杂志！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/08/bcaa9c02cdc86c850bed66bd80d62afc.jpg, createdBy=a6a15275344, createdName=幸福悠然1985, createdTime=Sat Feb 08 00:00:00 CST 2020, time=2020-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926204, encodeId=8ba592620475, content=这个杂志接受纯生信吗？刚被隔壁biomed res int拒了，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Sun Feb 21 19:58:55 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590496, encodeId=256a5904966b, content=隔一个月直接接收了肥皂冒泡 2020-04-27 00:00:00 发表: 小修后，已经20多天了，一直是with editor ……, beContent=肥皂冒泡 2020-04-27 00:00:00 发表: 小修后，已经20多天了，一直是with editor ……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/bd660048b8b8a90d25fec71869d21df4.jpg, createdBy=fb441602893, createdName=肥皂冒泡, createdTime=Sat May 09 00:00:00 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587770, encodeId=5f3958e77021, content=请问疫情审稿延迟了？我under review一个月没动静呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec4a2554356, createdName=1254b90bm49(暂无昵称), createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586651, encodeId=a89e5866515c, content=纯生信还要吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/tibII0b4lRfFhLvFjAa2ia6c3aZRprZkkvq9RQBKcYG8pOJSRjqhQLLGgA63ogn5sAj4Md9y5D9MWu0zDrpLQgtQ/132, createdBy=b89a5237824, createdName=小米7909, createdTime=Sun Mar 15 00:00:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800711, encodeId=9711800e110b, content=快一个月了只到reviewer invited阶段，有遇到过吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a83e5207147, createdName=1475071cm29(暂无昵称), createdTime=Wed Jul 01 05:55:12 CST 2020, time=2020-07-01, status=1, ipAttribution=)]

2021-02-21 ms1000000995331571

这个杂志接受纯生信吗？刚被隔壁biomed res int拒了，谢谢

91 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=999340, encodeId=f152999340cc, content=我的论文Required Reviews Completed，这个大概需要多久啊？接收的概率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de965352151, createdName=刘娟5835, createdTime=Wed Jul 14 11:23:48 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914157, encodeId=84a791415e29, content=2020.9.15投稿，2020.9.17 review 2021.1.6reject 中间发了两次邮件询问审稿情况，均恢复说只有一个审稿人意见返回，结果今天回复找不到审稿人，拒稿，心累…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19615409816, createdName=ms8000000599164467, createdTime=Wed Jan 06 18:42:43 CST 2021, time=2021-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587662, encodeId=8fa358e662c1, content=刚投了一篇，被拒了小米 2020-03-15 00:00:00 发表: 纯生信还要吗, beContent=小米 2020-03-15 00:00:00 发表: 纯生信还要吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Sat Mar 28 00:00:00 CST 2020, time=2020-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219190, encodeId=ba0e121919097, content=请问怎么能够找到这个杂志的格式要求啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7b58152381, createdName=ms9000000125016448, createdTime=Thu May 12 22:30:01 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584426, encodeId=3bb0584426b7, content=您好！病理个案好投吗？caomeng13001_34315622 2019-09-03 发表:: 研究方向：病理学;肿瘤病理;细胞生物学接收率：约50% 审稿时间：约2个月在这个杂志投过两篇论文，总体感觉是很nice的杂志。两次都是4月中旬投稿，with editor大概三五天，就开始under review。5月底收到审稿人的修改意见，意见很专业也很细致。第一次小修用了大约半个月，第二次大修将近三个月。两次都是修回后半个月内接收。推荐病理方向相关的论文试一试这个杂志！caomeng13001_34315622 2019-09-03 15:38:00 发表: 在这个杂志投过两篇论文，总体感觉是很nice的杂志。两次都是4月中旬投稿，with editor大概三五天，就开始under review。5月底收到审稿人的修改意见，意见很专业也很细致。第一次小修用了大约半个月，第二次大修将近三个月。两次都是修回后半个月内接收。推荐病理方向相关的论文试一试这个杂志！, beContent=caomeng13001_34315622 2019-09-03 发表:: 研究方向：病理学;肿瘤病理;细胞生物学接收率：约50% 审稿时间：约2个月在这个杂志投过两篇论文，总体感觉是很nice的杂志。两次都是4月中旬投稿，with editor大概三五天，就开始under review。5月底收到审稿人的修改意见，意见很专业也很细致。第一次小修用了大约半个月，第二次大修将近三个月。两次都是修回后半个月内接收。推荐病理方向相关的论文试一试这个杂志！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/08/bcaa9c02cdc86c850bed66bd80d62afc.jpg, createdBy=a6a15275344, createdName=幸福悠然1985, createdTime=Sat Feb 08 00:00:00 CST 2020, time=2020-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926204, encodeId=8ba592620475, content=这个杂志接受纯生信吗？刚被隔壁biomed res int拒了，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Sun Feb 21 19:58:55 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590496, encodeId=256a5904966b, content=隔一个月直接接收了肥皂冒泡 2020-04-27 00:00:00 发表: 小修后，已经20多天了，一直是with editor ……, beContent=肥皂冒泡 2020-04-27 00:00:00 发表: 小修后，已经20多天了，一直是with editor ……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/bd660048b8b8a90d25fec71869d21df4.jpg, createdBy=fb441602893, createdName=肥皂冒泡, createdTime=Sat May 09 00:00:00 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587770, encodeId=5f3958e77021, content=请问疫情审稿延迟了？我under review一个月没动静呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec4a2554356, createdName=1254b90bm49(暂无昵称), createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586651, encodeId=a89e5866515c, content=纯生信还要吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/tibII0b4lRfFhLvFjAa2ia6c3aZRprZkkvq9RQBKcYG8pOJSRjqhQLLGgA63ogn5sAj4Md9y5D9MWu0zDrpLQgtQ/132, createdBy=b89a5237824, createdName=小米7909, createdTime=Sun Mar 15 00:00:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800711, encodeId=9711800e110b, content=快一个月了只到reviewer invited阶段，有遇到过吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a83e5207147, createdName=1475071cm29(暂无昵称), createdTime=Wed Jul 01 05:55:12 CST 2020, time=2020-07-01, status=1, ipAttribution=)]

2020-05-09 肥皂冒泡

隔一个月直接接收了肥皂冒泡 2020-04-27 00:00:00 发表:
小修后，已经20多天了，一直是with editor ……

肥皂冒泡 2020-04-27 00:00:00 发表: 小修后，已经20多天了，一直是with editor ……

126 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=999340, encodeId=f152999340cc, content=我的论文Required Reviews Completed，这个大概需要多久啊？接收的概率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de965352151, createdName=刘娟5835, createdTime=Wed Jul 14 11:23:48 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914157, encodeId=84a791415e29, content=2020.9.15投稿，2020.9.17 review 2021.1.6reject 中间发了两次邮件询问审稿情况，均恢复说只有一个审稿人意见返回，结果今天回复找不到审稿人，拒稿，心累…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19615409816, createdName=ms8000000599164467, createdTime=Wed Jan 06 18:42:43 CST 2021, time=2021-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587662, encodeId=8fa358e662c1, content=刚投了一篇，被拒了小米 2020-03-15 00:00:00 发表: 纯生信还要吗, beContent=小米 2020-03-15 00:00:00 发表: 纯生信还要吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Sat Mar 28 00:00:00 CST 2020, time=2020-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219190, encodeId=ba0e121919097, content=请问怎么能够找到这个杂志的格式要求啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7b58152381, createdName=ms9000000125016448, createdTime=Thu May 12 22:30:01 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584426, encodeId=3bb0584426b7, content=您好！病理个案好投吗？caomeng13001_34315622 2019-09-03 发表:: 研究方向：病理学;肿瘤病理;细胞生物学接收率：约50% 审稿时间：约2个月在这个杂志投过两篇论文，总体感觉是很nice的杂志。两次都是4月中旬投稿，with editor大概三五天，就开始under review。5月底收到审稿人的修改意见，意见很专业也很细致。第一次小修用了大约半个月，第二次大修将近三个月。两次都是修回后半个月内接收。推荐病理方向相关的论文试一试这个杂志！caomeng13001_34315622 2019-09-03 15:38:00 发表: 在这个杂志投过两篇论文，总体感觉是很nice的杂志。两次都是4月中旬投稿，with editor大概三五天，就开始under review。5月底收到审稿人的修改意见，意见很专业也很细致。第一次小修用了大约半个月，第二次大修将近三个月。两次都是修回后半个月内接收。推荐病理方向相关的论文试一试这个杂志！, beContent=caomeng13001_34315622 2019-09-03 发表:: 研究方向：病理学;肿瘤病理;细胞生物学接收率：约50% 审稿时间：约2个月在这个杂志投过两篇论文，总体感觉是很nice的杂志。两次都是4月中旬投稿，with editor大概三五天，就开始under review。5月底收到审稿人的修改意见，意见很专业也很细致。第一次小修用了大约半个月，第二次大修将近三个月。两次都是修回后半个月内接收。推荐病理方向相关的论文试一试这个杂志！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/08/bcaa9c02cdc86c850bed66bd80d62afc.jpg, createdBy=a6a15275344, createdName=幸福悠然1985, createdTime=Sat Feb 08 00:00:00 CST 2020, time=2020-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926204, encodeId=8ba592620475, content=这个杂志接受纯生信吗？刚被隔壁biomed res int拒了，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Sun Feb 21 19:58:55 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590496, encodeId=256a5904966b, content=隔一个月直接接收了肥皂冒泡 2020-04-27 00:00:00 发表: 小修后，已经20多天了，一直是with editor ……, beContent=肥皂冒泡 2020-04-27 00:00:00 发表: 小修后，已经20多天了，一直是with editor ……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/bd660048b8b8a90d25fec71869d21df4.jpg, createdBy=fb441602893, createdName=肥皂冒泡, createdTime=Sat May 09 00:00:00 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587770, encodeId=5f3958e77021, content=请问疫情审稿延迟了？我under review一个月没动静呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec4a2554356, createdName=1254b90bm49(暂无昵称), createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586651, encodeId=a89e5866515c, content=纯生信还要吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/tibII0b4lRfFhLvFjAa2ia6c3aZRprZkkvq9RQBKcYG8pOJSRjqhQLLGgA63ogn5sAj4Md9y5D9MWu0zDrpLQgtQ/132, createdBy=b89a5237824, createdName=小米7909, createdTime=Sun Mar 15 00:00:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800711, encodeId=9711800e110b, content=快一个月了只到reviewer invited阶段，有遇到过吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a83e5207147, createdName=1475071cm29(暂无昵称), createdTime=Wed Jul 01 05:55:12 CST 2020, time=2020-07-01, status=1, ipAttribution=)]

2020-03-30 1254b90bm49(暂无昵称)

请问疫情审稿延迟了？我under review一个月没动静呢

135 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=999340, encodeId=f152999340cc, content=我的论文Required Reviews Completed，这个大概需要多久啊？接收的概率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de965352151, createdName=刘娟5835, createdTime=Wed Jul 14 11:23:48 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914157, encodeId=84a791415e29, content=2020.9.15投稿，2020.9.17 review 2021.1.6reject 中间发了两次邮件询问审稿情况，均恢复说只有一个审稿人意见返回，结果今天回复找不到审稿人，拒稿，心累…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19615409816, createdName=ms8000000599164467, createdTime=Wed Jan 06 18:42:43 CST 2021, time=2021-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587662, encodeId=8fa358e662c1, content=刚投了一篇，被拒了小米 2020-03-15 00:00:00 发表: 纯生信还要吗, beContent=小米 2020-03-15 00:00:00 发表: 纯生信还要吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Sat Mar 28 00:00:00 CST 2020, time=2020-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219190, encodeId=ba0e121919097, content=请问怎么能够找到这个杂志的格式要求啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7b58152381, createdName=ms9000000125016448, createdTime=Thu May 12 22:30:01 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584426, encodeId=3bb0584426b7, content=您好！病理个案好投吗？caomeng13001_34315622 2019-09-03 发表:: 研究方向：病理学;肿瘤病理;细胞生物学接收率：约50% 审稿时间：约2个月在这个杂志投过两篇论文，总体感觉是很nice的杂志。两次都是4月中旬投稿，with editor大概三五天，就开始under review。5月底收到审稿人的修改意见，意见很专业也很细致。第一次小修用了大约半个月，第二次大修将近三个月。两次都是修回后半个月内接收。推荐病理方向相关的论文试一试这个杂志！caomeng13001_34315622 2019-09-03 15:38:00 发表: 在这个杂志投过两篇论文，总体感觉是很nice的杂志。两次都是4月中旬投稿，with editor大概三五天，就开始under review。5月底收到审稿人的修改意见，意见很专业也很细致。第一次小修用了大约半个月，第二次大修将近三个月。两次都是修回后半个月内接收。推荐病理方向相关的论文试一试这个杂志！, beContent=caomeng13001_34315622 2019-09-03 发表:: 研究方向：病理学;肿瘤病理;细胞生物学接收率：约50% 审稿时间：约2个月在这个杂志投过两篇论文，总体感觉是很nice的杂志。两次都是4月中旬投稿，with editor大概三五天，就开始under review。5月底收到审稿人的修改意见，意见很专业也很细致。第一次小修用了大约半个月，第二次大修将近三个月。两次都是修回后半个月内接收。推荐病理方向相关的论文试一试这个杂志！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/08/bcaa9c02cdc86c850bed66bd80d62afc.jpg, createdBy=a6a15275344, createdName=幸福悠然1985, createdTime=Sat Feb 08 00:00:00 CST 2020, time=2020-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926204, encodeId=8ba592620475, content=这个杂志接受纯生信吗？刚被隔壁biomed res int拒了，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Sun Feb 21 19:58:55 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590496, encodeId=256a5904966b, content=隔一个月直接接收了肥皂冒泡 2020-04-27 00:00:00 发表: 小修后，已经20多天了，一直是with editor ……, beContent=肥皂冒泡 2020-04-27 00:00:00 发表: 小修后，已经20多天了，一直是with editor ……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/bd660048b8b8a90d25fec71869d21df4.jpg, createdBy=fb441602893, createdName=肥皂冒泡, createdTime=Sat May 09 00:00:00 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587770, encodeId=5f3958e77021, content=请问疫情审稿延迟了？我under review一个月没动静呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec4a2554356, createdName=1254b90bm49(暂无昵称), createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586651, encodeId=a89e5866515c, content=纯生信还要吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/tibII0b4lRfFhLvFjAa2ia6c3aZRprZkkvq9RQBKcYG8pOJSRjqhQLLGgA63ogn5sAj4Md9y5D9MWu0zDrpLQgtQ/132, createdBy=b89a5237824, createdName=小米7909, createdTime=Sun Mar 15 00:00:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800711, encodeId=9711800e110b, content=快一个月了只到reviewer invited阶段，有遇到过吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a83e5207147, createdName=1475071cm29(暂无昵称), createdTime=Wed Jul 01 05:55:12 CST 2020, time=2020-07-01, status=1, ipAttribution=)]

2020-03-15 小米7909

纯生信还要吗

251 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=999340, encodeId=f152999340cc, content=我的论文Required Reviews Completed，这个大概需要多久啊？接收的概率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de965352151, createdName=刘娟5835, createdTime=Wed Jul 14 11:23:48 CST 2021, time=2021-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914157, encodeId=84a791415e29, content=2020.9.15投稿，2020.9.17 review 2021.1.6reject 中间发了两次邮件询问审稿情况，均恢复说只有一个审稿人意见返回，结果今天回复找不到审稿人，拒稿，心累…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19615409816, createdName=ms8000000599164467, createdTime=Wed Jan 06 18:42:43 CST 2021, time=2021-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587662, encodeId=8fa358e662c1, content=刚投了一篇，被拒了小米 2020-03-15 00:00:00 发表: 纯生信还要吗, beContent=小米 2020-03-15 00:00:00 发表: 纯生信还要吗, objectType=tool_impact_factor, channel=null, level=null, likeNumber=117, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=560e5151026, createdName=14697858m50(暂无昵称), createdTime=Sat Mar 28 00:00:00 CST 2020, time=2020-03-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219190, encodeId=ba0e121919097, content=请问怎么能够找到这个杂志的格式要求啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c7b58152381, createdName=ms9000000125016448, createdTime=Thu May 12 22:30:01 CST 2022, time=2022-05-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584426, encodeId=3bb0584426b7, content=您好！病理个案好投吗？caomeng13001_34315622 2019-09-03 发表:: 研究方向：病理学;肿瘤病理;细胞生物学接收率：约50% 审稿时间：约2个月在这个杂志投过两篇论文，总体感觉是很nice的杂志。两次都是4月中旬投稿，with editor大概三五天，就开始under review。5月底收到审稿人的修改意见，意见很专业也很细致。第一次小修用了大约半个月，第二次大修将近三个月。两次都是修回后半个月内接收。推荐病理方向相关的论文试一试这个杂志！caomeng13001_34315622 2019-09-03 15:38:00 发表: 在这个杂志投过两篇论文，总体感觉是很nice的杂志。两次都是4月中旬投稿，with editor大概三五天，就开始under review。5月底收到审稿人的修改意见，意见很专业也很细致。第一次小修用了大约半个月，第二次大修将近三个月。两次都是修回后半个月内接收。推荐病理方向相关的论文试一试这个杂志！, beContent=caomeng13001_34315622 2019-09-03 发表:: 研究方向：病理学;肿瘤病理;细胞生物学接收率：约50% 审稿时间：约2个月在这个杂志投过两篇论文，总体感觉是很nice的杂志。两次都是4月中旬投稿，with editor大概三五天，就开始under review。5月底收到审稿人的修改意见，意见很专业也很细致。第一次小修用了大约半个月，第二次大修将近三个月。两次都是修回后半个月内接收。推荐病理方向相关的论文试一试这个杂志！, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/08/bcaa9c02cdc86c850bed66bd80d62afc.jpg, createdBy=a6a15275344, createdName=幸福悠然1985, createdTime=Sat Feb 08 00:00:00 CST 2020, time=2020-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926204, encodeId=8ba592620475, content=这个杂志接受纯生信吗？刚被隔壁biomed res int拒了，谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9d325448092, createdName=ms1000000995331571, createdTime=Sun Feb 21 19:58:55 CST 2021, time=2021-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590496, encodeId=256a5904966b, content=隔一个月直接接收了肥皂冒泡 2020-04-27 00:00:00 发表: 小修后，已经20多天了，一直是with editor ……, beContent=肥皂冒泡 2020-04-27 00:00:00 发表: 小修后，已经20多天了，一直是with editor ……, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/25/bd660048b8b8a90d25fec71869d21df4.jpg, createdBy=fb441602893, createdName=肥皂冒泡, createdTime=Sat May 09 00:00:00 CST 2020, time=2020-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=587770, encodeId=5f3958e77021, content=请问疫情审稿延迟了？我under review一个月没动静呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec4a2554356, createdName=1254b90bm49(暂无昵称), createdTime=Mon Mar 30 00:00:00 CST 2020, time=2020-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586651, encodeId=a89e5866515c, content=纯生信还要吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/tibII0b4lRfFhLvFjAa2ia6c3aZRprZkkvq9RQBKcYG8pOJSRjqhQLLGgA63ogn5sAj4Md9y5D9MWu0zDrpLQgtQ/132, createdBy=b89a5237824, createdName=小米7909, createdTime=Sun Mar 15 00:00:00 CST 2020, time=2020-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800711, encodeId=9711800e110b, content=快一个月了只到reviewer invited阶段，有遇到过吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a83e5207147, createdName=1475071cm29(暂无昵称), createdTime=Wed Jul 01 05:55:12 CST 2020, time=2020-07-01, status=1, ipAttribution=)]

2020-07-01 1475071cm29(暂无昵称)

快一个月了只到reviewer invited阶段，有遇到过吗？

112 2

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务